BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 31698633)

  • 1. The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics.
    Ni KW; Sun GZ
    Math Biosci Eng; 2019 Aug; 16(6):7671-7687. PubMed ID: 31698633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The identification of a common different gene expression signature in patients with colorectal cancer.
    Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS
    Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
    Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
    Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
    Li J; Liu X; Cui Z; Han G
    Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of key genes and biological pathways in lung adenocarcinoma via bioinformatics analysis.
    Wang Y; Zhou Z; Chen L; Li Y; Zhou Z; Chu X
    Mol Cell Biochem; 2021 Feb; 476(2):931-939. PubMed ID: 33130972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated bioinformatics analysis of microarray data from the GEO database to identify the candidate genes linked to poor prognosis in lung adenocarcinoma.
    Liu X; Li L; Xie X; Zhuang D; Hu C
    Technol Health Care; 2023; 31(2):579-592. PubMed ID: 36336945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databases.
    Yu Y; Tian X
    Medicine (Baltimore); 2020 May; 99(19):e20183. PubMed ID: 32384511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics.
    Li L; Zhu Z; Zhao Y; Zhang Q; Wu X; Miao B; Cao J; Fei S
    Sci Rep; 2019 May; 9(1):7827. PubMed ID: 31127138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of differentially expressed genes associated with lung adenocarcinoma via bioinformatics analysis.
    Yang X; Feng Q; Jing J; Yan J; Zeng Z; Zheng H; Cheng X
    Gen Physiol Biophys; 2021 Jan; 40(1):31-48. PubMed ID: 33655889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactive Verification Analysis of Multiple Sequencing Data for Identifying Potential Biomarker of Lung Adenocarcinoma.
    Fei H; Chen S; Xu C
    Biomed Res Int; 2020; 2020():8931419. PubMed ID: 33062704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
    Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ
    Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085
    [No Abstract]   [Full Text] [Related]  

  • 13. Elevated TOP2A and UBE2C expressions correlate with poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformatics.
    Guo W; Sun S; Guo L; Song P; Xue X; Zhang H; Zhang G; Wang Z; Qiu B; Tan F; Xue Q; Gao Y; Gao S; He J
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):821-841. PubMed ID: 32103339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.
    Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of crucial genes associated with lung adenocarcinoma by bioinformatic analysis.
    Dai JJ; Zhou WB; Wang B
    Medicine (Baltimore); 2020 Oct; 99(44):e23052. PubMed ID: 33126397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of lung adenocarcinoma biomarkers based on bioinformatic analysis and human samples.
    Dong S; Men W; Yang S; Xu S
    Oncol Rep; 2020 May; 43(5):1437-1450. PubMed ID: 32323809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tanshinone IIA suppresses the progression of lung adenocarcinoma through regulating CCNA2-CDK2 complex and AURKA/PLK1 pathway.
    Li Z; Zhang Y; Zhou Y; Wang F; Yin C; Ding L; Zhang S
    Sci Rep; 2021 Dec; 11(1):23681. PubMed ID: 34880385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment.
    Wei T; Song J; Liang K; Li L; Mo X; Huang Z; Chen G; Mao N; Yang J
    J Cancer Res Clin Oncol; 2021 Apr; 147(4):1049-1064. PubMed ID: 33387038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Potential Key Genes and Prognostic Biomarkers of Lung Cancer Based on Bioinformatics.
    Cai K; Xie Z; Liu Y; Wu J; Song H; Liu W; Wang X; Xiong Y; Gan S; Sun Y
    Biomed Res Int; 2023; 2023():2152432. PubMed ID: 36714024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis.
    Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H
    BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.